dr. randy sweis on impact of atezolizumab approval in bladder cancer
Published 8 years ago • 528 plays • Length 1:28Download video MP4
Download video MP3
Similar videos
-
7:05
the fda approval of atezolizumab in bladder cancer
-
1:07
dr. sweis on immunotherapy in genitourinary cancer
-
1:10
dr. steinberg on the fda approval of atezolizumab in bladder cancer
-
1:20
dr. rosenberg on future use of atezolizumab in bladder cancer
-
0:46
dr. sonpavde on the need for phase 3 data with pembrolizumab or atezolizumab in bladder cancer
-
1:25
dr. sweis on trend toward immunotherapy in gu malignancies
-
30:04
raynaud's and systemic sclerosis
-
46:02
efl049 - artificial intelligence in the diagnosis of cushing syndrome
-
2:00
main causes of bladder cancer
-
1:36
dr. sweis on sequencing of therapies in prostate cancer
-
1:47
dr. sonpavde on the safety profile of erdafitinib in bladder cancer
-
1:03
sangeetha palakurthi on fda approval of atezolizumab in nsclc
-
2:08
dr. david nanus on atezolizumab for urothelial bladder cancer
-
1:25
dr. sonpavde on the next steps for atezolizumab in urothelial carcinoma
-
1:10
dr. jean hoffman-censits on the future of atezolizumab in bladder cancer
-
1:33
dr. sonpavde on novel prognostic marker for atezolizumab in bladder cancer
-
1:27
fda approval of atezolizumab for nsclc
-
1:08
dr. sonpavde on accelerated approval of erdafitinib in bladder cancer
-
0:46
dr. hoffman-censits discusses immunotherapy in bladder cancer
-
4:48
gefitinib approved for nsclc, atezolizumab shrinks bladder tumors, and more
-
0:34
can bladder cancer be cured? | urochannel
-
1:05
dr. jean hoffman-censits on the results of a phase ii trial studying atezolizumab in bladder cancer